RenovoRx, Inc. (RNXT)
1.67
+0.19
(+12.84%)
USD |
NASDAQ |
Aug 28, 16:00
1.70
+0.03
(+1.80%)
After-Hours: 20:00
RenovoRx 1 Year Total Returns (Daily) : 76.23% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 76.23% |
| August 27, 2026 | 60.07% |
| August 26, 2026 | 61.29% |
| August 25, 2026 | 58.06% |
| August 24, 2026 | 32.94% |
| August 21, 2026 | 47.75% |
| August 20, 2026 | 51.72% |
| August 19, 2026 | 42.72% |
| August 18, 2026 | 24.47% |
| August 17, 2026 | 25.59% |
| August 14, 2026 | 12.90% |
| August 13, 2026 | 3.28% |
| August 12, 2026 | 1.82% |
| August 11, 2026 | 3.14% |
| August 10, 2026 | 1.75% |
| August 07, 2026 | -6.67% |
| August 06, 2026 | -4.17% |
| August 05, 2026 | -13.11% |
| August 04, 2026 | -14.05% |
| August 03, 2026 | -12.40% |
| July 31, 2026 | -22.72% |
| July 30, 2026 | -21.57% |
| July 29, 2026 | -26.39% |
| July 28, 2026 | -27.42% |
| July 27, 2026 | -24.01% |
| Date | Value |
|---|---|
| July 24, 2026 | -33.44% |
| July 23, 2026 | -32.72% |
| July 22, 2026 | -32.38% |
| July 21, 2026 | -31.97% |
| July 20, 2026 | -33.56% |
| July 17, 2026 | -33.44% |
| July 16, 2026 | -32.23% |
| July 15, 2026 | -34.88% |
| July 14, 2026 | -39.29% |
| July 13, 2026 | -28.92% |
| July 10, 2026 | -30.59% |
| July 09, 2026 | -28.53% |
| July 08, 2026 | -30.77% |
| July 07, 2026 | -29.73% |
| July 06, 2026 | -30.32% |
| July 02, 2026 | -29.22% |
| July 01, 2026 | -24.79% |
| June 30, 2026 | -25.48% |
| June 29, 2026 | -24.22% |
| June 26, 2026 | -30.10% |
| June 25, 2026 | -32.61% |
| June 24, 2026 | -32.89% |
| June 23, 2026 | -35.41% |
| June 22, 2026 | -34.04% |
| June 18, 2026 | -33.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Enanta Pharmaceuticals, Inc. | 56.50% |
| Travere Therapeutics, Inc. | 271.0% |
| REGENXBIO, Inc. | 7.21% |
| Krystal Biotech, Inc. | 133.1% |
| ACADIA Pharmaceuticals, Inc. | 10.98% |